A Potent Brucella abortus 2308 Δery Live Vaccine Allows for the Differentiation between Natural and Vaccinated Infection

Junbo Zhang; Shuanghong Yin; Fei Guo; Ren Meng; Chuangfu Chen; Hui Zhang; Zhiqiang Li; Qiang Fu; Huijun Shi; Shengwei Hu; Wei Ni; Tiansen Li; Ke Zhang

doi:10.1007/s12275-014-3689-9

Articles

Page Path: HOME > J. Microbiol > Volume 52(8); 2014 > Article

Research Support, Non-U.S. Gov't
A Potent Brucella abortus 2308 Δery Live Vaccine Allows for the Differentiation between Natural and Vaccinated Infection: Junbo Zhang ¹, Shuanghong Yin ², Fei Guo ², Ren Meng ¹, Chuangfu Chen ¹, Hui Zhang ¹, Zhiqiang Li ¹, Qiang Fu ¹, Huijun Shi ¹, Shengwei Hu ¹, Wei Ni ³, Tiansen Li ¹, Ke Zhang ¹; Journal of Microbiology 2014;52(8):681-688.
DOI: https://doi.org/10.1007/s12275-014-3689-9
Published online: July 4, 2014

¹College of Animal Science and Technology, Shihezi University, Shihezi 832003, P. R. China, ²College of Medicine, Shihezi University, Shihezi 832003, P. R. China, ³College of Life Sciences, Shihezi University, Xinjiang 832000, P. R. China¹College of Animal Science and Technology, Shihezi University, Shihezi 832003, P. R. China, ²College of Medicine, Shihezi University, Shihezi 832003, P. R. China, ³College of Life Sciences, Shihezi University, Xinjiang 832000, P. R. China

Corresponding author: Chuangfu Chen , Tel: +86-0993-2058002,

Received: 30 December 2013 • Revised: 24 April 2014 • Accepted: 1 May 2014

prev next

54 Views
0 Download
15 Crossref
16 Scopus

Full Article

Abstract

Brucellosis is a globally distributed zoonotic disease that causes animal and human diseases. However, the current Brucella abortus vaccines (S19 and RB51) are deficient; they can cause abortion in pregnant animals. Moreover, when the vaccine S19 is used, tests cannot differentiate natural from vaccinated infection. Therefore, a safer and more potent vaccine is needed. A Brucella abortus 2308 ery promoter mutant (Δery) was constructed to overcome these drawbacks. The growth of the Δery mutant was significantly attenuated in macrophages and mice and induced high protective immunity in mice. Moreover, Δery induced an anti-Brucellaspecific IgG (immunoglobulin G) response and stimulated the expression of interferon-gamma (INF-γ) and interleukin-4 (IL-4). Furthermore, the expression of EryA antigen allowed for the serological differentiation between natural and vaccinated infection in mice. These results indicate that the Δery mutant is a potential attenuated live vaccine candidate against virulent Brucella abortus 2308 (S2308) infection.

Keywords: Brucella abortus 2308;ery promoter mutant;live attenuated vaccine;EryA

Figure & Data

References

Citations

Citations to this article as recorded by

Disruption of Erythritol Catabolism via the Deletion of Fructose-Bisphosphate Aldolase (Fba) and Transaldolase (Tal) as a Strategy to Improve the Brucella Rev1 Vaccine
Aitor Elizalde-Bielsa, Leticia Lázaro-Antón, María Jesús de Miguel, Pilar M. Muñoz, Raquel Conde-Álvarez, Amaia Zúñiga-Ripa
International Journal of Molecular Sciences.2024; 25(20): 11230. CrossRef
Establishment of picodroplet-based co-culture system to improve erythritol production in Yarrowia lipolytica
Shuang Li, Yuan Zhang, Lu Li, Yaomeng Yuan, Haoxuan Sun, Xin-Hui Xing, Xiaoyan Wang, Chong Zhang
Biochemical Engineering Journal.2023; 198: 109036. CrossRef
Characterization of Brucella abortus Mutant A19mut2, a Potential DIVA Vaccine Candidate with a Modification on Lipopolysaccharide
Hosny Ahmed Abdelgawad, Zhengmin Lian, Yi Yin, Tian Fang, Mingxing Tian, Shengqing Yu
Vaccines.2023; 11(7): 1273. CrossRef
Evaluation of Brucellosis Vaccines: A Comprehensive Review
Mohsen Heidary, Shirin Dashtbin, Roya Ghanavati, Marzie Mahdizade Ari, Narjess Bostanghadiri, Atieh Darbandi, Tahereh Navidifar, Malihe Talebi
Frontiers in Veterinary Science.2022;[Epub] CrossRef
Advances and prospects of transcription‐factor‐based biosensors in high‐throughput screening for cell factories construction
Changfan Li, Chang Wang, Jiang Zhu, Feng Xue, Xiaoman Sun, Yang Gu
Food Bioengineering.2022; 1(2): 135. CrossRef
Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model
Ali Uslu, Osman Erganis
Molecular Immunology.2021; 133: 44. CrossRef
Insights into irr and rirA gene regulation on the virulence of Brucella melitensis M5-90
Huan Zhang, Benben Wang, Wenxing Wu, Xiaoyu Deng, Zhiran Shao, Jihai Yi, Zhen Wang, Ningning Yang, Yong Wang, Yuanzhi Wang, Chuangfu Chen
Canadian Journal of Microbiology.2020; 66(5): 351. CrossRef
Combining genetically-encoded biosensors with high throughput strain screening to maximize erythritol production in Yarrowia lipolytica
Xueliang Qiu, Peng Xu, Xinrui Zhao, Guocheng Du, Juan Zhang, Jianghua Li
Metabolic Engineering.2020; 60: 66. CrossRef
Research progress on the role of immune cells in Brucella infection
Jin Zhang
Infection International.2018; 7(1): 23. CrossRef
Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant
Zhiqiang Li, Shuli Wang, Hui Zhang, Li Xi, Jinliang Zhang, Xiaogen Zhang, Qingfeng Zhou, Jihai Yi, Min Li, Weihua Zhang, Junbo Zhang
Microbial Pathogenesis.2018; 124: 250. CrossRef
Expression and regulation of the ery operon of Brucella melitensis in human trophoblast cells
Hui Zhang, Xiaoxia Dou, Zhiqiang Li, Yu Zhang, Jing Zhang, Fei Guo, Yuanzhi Wang, Zhen Wang, Tiansen Li, Xinli Gu, Chuangfu Chen
Experimental and Therapeutic Medicine.2016; 12(4): 2723. CrossRef
Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models
Ae Jeong KWON, Ja Young MOON, Won Kyong KIM, Suk KIM, Jin HUR
Journal of Veterinary Medical Science.2016; 78(10): 1541. CrossRef
Meta-Analysis and Advancement of Brucellosis Vaccinology
Tatiane F. Carvalho, João Paulo A. Haddad, Tatiane A. Paixão, Renato L. Santos, Roy Martin Roop
PLOS ONE.2016; 11(11): e0166582. CrossRef
The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice
Yu Zhang, Tiansen Li, Jing Zhang, Zhiqiang Li, Yan Zhang, Zhen Wang, Hanping Feng, Yuanzhi Wang, Chuangfu Chen, Hui Zhang
World Journal of Microbiology and Biotechnology.2016;[Epub] CrossRef
A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy
Zhi-Qiang Li, Jing-Xue Shi, Wen-Dong Fu, Yu Zhang, Jing Zhang, Zhen Wang, Tian-Sen Li, Chuang-Fu Chen, Fei Guo, Hui Zhang
Molecular Immunology.2015; 66(2): 276. CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

A Potent Brucella abortus 2308 Δery Live Vaccine Allows for the Differentiation between Natural and Vaccinated Infection

J. Microbiol. 2014;52(8):681-688. Published online July 4, 2014

DOI: https://doi.org/10.1007/s12275-014-3689-9

Related articles